Axodin Pharmaceuticals Private Limited

Axodin Pharmaceuticals Private Limited - pharma in Ambala, Haryana, India. FY 2026 financials & compliance.
CIN U24230HR2016PTC064965 Incorporated 11 July 2016 ROC Delhi HQ Ambala, Haryana, India
Active Private Limited Company pharma MSME · Micro
Revenue · FY 2026
₹4.68 Cr
▼ 1% YoY
Net profit · FY 2026
₹9.54 Lakh
Net margin 2%
EBITDA · FY 2026
₹29.77 Lakh
EBITDA margin 6.4%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Open charges
₹1.21 Cr
Satisfied ₹25 Lakh
Company age
10 yrs
Est. 2016
Directors on board
2
As per MCA filings

About Axodin Pharmaceuticals Private Limited

Data last updated:

Axodin Pharmaceuticals Private Limited is a private limited company based in Ambala, Haryana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 11 July 2016 and has been in existence for over 10 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24230HR2016PTC064965. Its GSTIN is 06AAOCA6393H1ZA (Haryana).

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Darshana Devi and Rahul Saini.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at 39/8/2 Markandey Complex Sena Nagar P.O Dhulkot, Ambala, Haryana, India – 134003.

As per the financials filed for FY 2026, the company reported a revenue of ₹4.68 Cr, a decline of 1% compared to the previous year. For the same year it recorded a net profit of ₹9.54 Lakh (net margin 2%) and EBITDA of ₹29.77 Lakh (EBITDA margin 6.4%). Revenue has grown at a compounded annual rate (CAGR) of 4% over three years and 12% over five years.

The company is associated with 2 brands: Axodin Pharma and Axodin Pharmaceuticals Private Limited. As per MCA filings, the company has open charges of ₹1.21 Cr and satisfied charges of ₹25 Lakh on record. Court records list 14 cases involving the company, including 14 filed by the company; 1 case is pending.

Axodin Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-01-0002045). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website axodinpharma.com.

Company details

CIN U24230HR2016PTC064965
Registration Number 064965
Incorporation Date 11 July 2016
ROC Delhi
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-HR-01-0002045

Recognitions & Rankings of Axodin Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Micro (2021-22)
Udyam number
UDYAM-HR-01-0002045

Contact details

Axodin Pharmaceuticals Private Limited's registered office is in Ambala, Haryana. Its website is axodinpharma.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    39/8/2 Markandey Complex Sena Nagar P.O Dhulkot, Ambala, Haryana, India – 134003
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Axodin Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Axodin Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Axodin Pharmaceuticals operates two associated brands: Axodin Pharma and Axodin Pharmaceuticals Private Limited. Each brand links to its own profile.

BrandDescriptionWebsite
PCD Pharma Franchise for distributing pharmaceutical products in specified areas.axodin.com
Supply of common medicines and drugs in the pharmaceutical sector.axodinpharma.com

Business activity

The main business activity of Axodin Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GWholesale and retail trade; repair of motor vehicles and motorcycles46Wholesale trade, except of motor vehicles and motorcycles

To see the full business activity and turnover split of Axodin Pharmaceuticals Private Limited, buy the company report.

Financials of Axodin Pharmaceuticals Private Limited

FY 2026 filings available

Axodin Pharmaceuticals Private Limited reported revenue of ₹4.68 Cr (down 1% YoY) for FY 2026.

Revenue · FY 2026
₹4.68 Cr ▼ 1%
Net profit · FY 2026
₹9.54 Lakh margin 2%
EBITDA · FY 2026
₹29.77 Lakh margin 6.4%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 1%
3 years · compounded
▲ 4%
5 years · compounded
▲ 12%
EBITDA CAGR growth
1 year
▲ 6%
3 years · compounded
▲ 7%
5 years · compounded
▲ 16%

Revenue fell 1% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 12%. EBITDA rose 6% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Profit and Loss Statement
Revenue from Operations₹4.68 Cr
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹29.77 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹9.54 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Profitability
EBITDA Margin6.4%
Net Profit Margin2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Axodin Pharmaceuticals Private Limited, buy the company report.

Board of directors of Axodin Pharmaceuticals Private Limited

Axodin Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Darshana DeviDirector25 Jul 201610 Years 3 MonthsCurrent
Rahul SainiDirector11 Jul 201610 Years 4 MonthsCurrent

Auditor

Axodin Pharmaceuticals Private Limited is audited by VIJAY GUPTA & JAIN for the financial year 2026.

Auditor firmFinancial yearFirm registration number
VIJAY GUPTA & JAINFY 2026009471N

Shareholding

The shareholding of Axodin Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2026, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2026FY 2025FY 2024FY 2023FY 2022
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Axodin Pharmaceuticals Private Limited, buy the company report.

Charges & borrowings

Open charges
₹1.21 Cr
Satisfied charges
₹25 Lakh
Breakdown by lending institutions
Hdfc Bank Limited₹1.21 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
05 Dec 2022100656904Hdfc Bank Limited₹20.91 LakhOpen
01 Jul 2020100369944Hdfc Bank Limited₹1 CrOpen
12 Oct 2016100057670Others₹25 LakhSatisfied

To see the full charge records of Axodin Pharmaceuticals Private Limited, buy the company report.

Total charge records: 3 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Axodin Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Axodin Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
06AAOCA6393H1ZAHaryanaActive01 Jul 2017

To see the full GST registrations and return filing status of Axodin Pharmaceuticals Private Limited, buy the company report.

Recent activity

Axodin Pharmaceuticals Private Limited has 3 board changes on record since 2016: 2 appointments and 1 cessation. The latest: Siri Ram ceased to be Director on 05 Aug 2016.

Filing
Axodin Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Delhi.
AGM
Axodin Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Hdfc Bank Limited of Rs. 100.00 Lakh registered on 01 Jul 2020 with Charge ID 100369944 was modified on 07 Sep 2023.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 20.91 Lakh with Charge ID 100656904 was registered on 05 Dec 2022.
Charges
A charge registered on 12 Oct 2016 via Charge ID 100057670 with Others was fully satisfied on 07 Jul 2020.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 100.00 Lakh with Charge ID 100369944 was registered on 01 Jul 2020.
Charges
A charge with Others of Rs. 25.00 Lakh registered on 12 Oct 2016 with Charge ID 100057670 was modified on 09 Apr 2019.
Charges
A charge with Others amounted to Rs. 25.00 Lakh with Charge ID 100057670 was registered on 12 Oct 2016.
Ceased
Siri Ram ceased to be Director.
Appointed
Darshana Devi was appointed as Director.
Appointed
Rahul Saini was appointed as Director.
Incorporation
11 Jul 2016
Axodin Pharmaceuticals Private Limited was registered on 11 Jul 2016 with Roc Delhi & aged 10 years 4 months as per MCA records.

Frequently asked questions

Axodin Pharmaceuticals is an active private limited company based in Ambala, Haryana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 11 July 2016 (10+ years old) and is registered under CIN U24230HR2016PTC064965.

Axodin Pharmaceuticals has 2 current directors:

The latest financial statements of Axodin Pharmaceuticals on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.

The GSTIN of Axodin Pharmaceuticals is 06AAOCA6393H1ZA, registered in Haryana.

The CIN (Corporate Identification Number) of Axodin Pharmaceuticals is U24230HR2016PTC064965. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Axodin Pharmaceuticals has 14 court cases on record: 14 filed by the company. 1 is pending.

Axodin Pharmaceuticals was incorporated on 11 July 2016, making it 10+ years old. It is registered with the Registrar of Companies, Delhi.

Siri Ram ceased to be Director on 05 Aug 2016. Darshana Devi was appointed as Director on 25 Jul 2016. Rahul Saini was appointed as Director on 11 Jul 2016.

Yes, Axodin Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-HR-01-0002045).

Axodin Pharmaceuticals can be reached through the website axodinpharma.com. Its registered office is in Ambala, Haryana, India.